ALOETTE COSMETICS OF NEW BRUNSWICKBusiness Directories,Company Directories

Company Name: Corporate Name:	ALOETTE COSMETICS OF NEW BRUNSWICK
Company Title:
Company Description:
Keywords to Search:
Company Address:	5 Israel Lane,SAINT JOHN,NB,Canada
ZIP Code: Postal Code:	E2N
Telephone Number:	5066489070
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	66860
USA SIC Description:	COSMETICS & PERFUMES
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
ALPINE MOTORS
ALPINE MOTORS INC
ALOETTE COSMETICS OF NEW BRUNS

Next company profile:
ALLSTATE INSURANCE COMPANY OF CANA
ALLSTATE INSURANCE COMPANY OF CANA
ALLSTATE INSURANCE CO-CANADA

Company News:

Lung Cancer - Medscape
Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer Read the latest
Small Cell Lung Cancer in 2024: Treatment Advances - Medscape
Dr Kris reviews the latest treatment advances in small cell lung cancer, including new standards of care and emerging therapies in 2024
Osimertinib OS Benefit Persists in NSCLC - Medscape
Osimertinib (Tagrisso, AstraZeneca), continues to provide an overall survival (OS) benefit after definitive chemoradiotherapy (CRT) in patients with unresectable stage III epidermal growth factor
Why a New Inhalable Lung Cancer Treatment Is So Promising
Study showed that exosomes (tiny spheres released by cells) can deliver potent immunotherapy to lung cancer tumors
Two Lung Cancer Drugs Recommended by EMA - Medscape
Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer
Is IO Monotherapy the New Standard of Care in Advanced NSCLC? - Medscape
Merck has released provocative but limited findings from the KEYNOTE-042 trial that indicate better outcomes for first-line pembrolizumab vs standard chemotherapy in advanced non-small cell lung
Zenocutuzumab Effective Against NRG1 Fusion Cancers - Medscape
The bispecific antibody shows particularly promising results in non–small cell lung cancer (NSCLC) and pancreatic cancer patients, with responses lasting a median of 11 1 months
Changes in the Treatment Landscape of Early-Stage Non–Small Cell Lung . . .
Narjust Florez, MD, reflects on the significant changes in the treatment landscape of early-stage non-small cell lung cancer in recent years
Evaluation and Management of Small Pulmonary Nodules - Page 3 - Medscape
Common benign etiologies of lung nodules with an air bronchogram include pulmonary lymphoma, sarcoidosis and round pneumonia [35, 55, 56] Cavitation can be present in both benign and malignant
Cetuximab in Advanced NSCLC Trial Published - Medscape
Adding cetuximab to standard platinum-based chemotherapy for patients with advanced non-small-cell lung cancer (NSCLC) confers a small survival benefit and might represent a new treatment option